Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Enterprise Value (2022 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Enterprise Value came in at -$41.5 million in Q1 2026, down 3760.12% YoY from $1.1 million in Q1 2025, and down 143.84% on a QoQ basis from -$17.0 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Enterprise Value (2022 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 7 years of Enterprise Value data on file, last reported at -$41.5 million in Q1 2026.

  • Quarterly Enterprise Value fell 3760.12% year-over-year to -$41.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$41.5 million (down 3760.12% YoY) and the FY2025 annual result came in at -$17.0 million, down 378.53% from the prior year.
  • Enterprise Value eased to -$41.5 million in Q1 2026, from -$17.0 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$1.1 million in Q1 2025 to a low of -$41.5 million in Q1 2026.
  • A 5-year average of -$8.8 million and a median of -$7.6 million in 2022 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2022 — Enterprise Value plunged 149361.29% — and 2025, when it soared 87.23%.
  • Tracing CNTN's Enterprise Value over 5 years: stood at -$6.5 million in 2022, then tumbled by 67.96% to -$10.9 million in 2023, then soared by 67.45% to -$3.6 million in 2024, then tumbled by 378.53% to -$17.0 million in 2025, then plunged by 143.84% to -$41.5 million in 2026.
  • The last three Enterprise Value figures came in at -$41.5 million (Q1 2026), -$17.0 million (Q4 2025), and -$7.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 574.32 Mn
Mar 31, 2026 637.67 Mn
Dec 31, 2025 100.44 Mn
Sep 30, 2025 12.86 Mn
Jun 30, 2025 3.34 Mn
Mar 31, 2025 1.79 Mn
Dec 31, 2024 -927,892.34
Sep 30, 2024 -1.59 Mn
Jun 30, 2024 -4.03 Mn
Mar 31, 2024 67.62 Mn
Dec 31, 2023 -961,813.49
Sep 30, 2023 1.31 Bn
Jun 30, 2023 2.30 Bn
Mar 31, 2023 3.42 Bn
Dec 31, 2022 1.68 Bn
Sep 30, 2022 3.49 Bn
Jun 30, 2022 3.38 Bn
Mar 31, 2022 6.81 Bn